Alnylam Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Alnylam Pharmaceuticals Inc
TickerALNY
CIK #0001178670
CUSIP02043Q107
SectorLife Sciences - Pharmaceutical Preparations
Address300 Third Street, Cambridge, MA 02142
Source [EDGAR]
CIK Filing 2011 - 2025
[0001178670] 10-K
[0001178670] 10-Q
[0001178670] 3
[0001178670] 4
[0001178670] 5
[0001178670] 8-K
[0001178670] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Capital Research Global Investors Alnylam Pharmaceuticals Inc [2025-02-13] 0.0
Capital World Investors Alnylam Pharmaceuticals Inc [2022-09-09] 10.7
Price T Rowe Associates Inc /MD/ Alnylam Pharmaceuticals Inc [2022-02-14] 5.4
Baillie Gifford & Co Alnylam Pharmaceuticals Inc [2020-02-03] 7.34
Price T Rowe Associates Inc /MD/ Alnylam Pharmaceuticals Inc [2017-12-11] 11.7
BlackRock Inc Alnylam Pharmaceuticals Inc [2017-01-30] 5.1
Dodge & Cox Alnylam Pharmaceuticals Inc [2016-12-09] 10.6
Vanguard Group Inc Alnylam Pharmaceuticals Inc [2016-02-10] 5.95
BlackRock Inc Alnylam Pharmaceuticals Inc [2016-01-28] 5.1
Sanofi Alnylam Pharmaceuticals Inc [2014-03-05] 12.0
Price T Rowe Associates Inc /MD/ Alnylam Pharmaceuticals Inc [2014-02-12] 6.0
Vanguard Specialized Funds Alnylam Pharmaceuticals Inc [2014-02-04] 6.47
Wellington Management Co LLP Alnylam Pharmaceuticals Inc [2013-12-10] 12.11
Alnylam Pharmaceuticals Inc Regulus Therapeutics Inc [2013-02-14] 17.2
Form 3/4/5 Filer 2011 - 2025
Alnylam Pharmaceuticals Inc
Bonney Michael W
Greenstreet Yvonne
Poulton Jeffrey V.
Fitzgerald Kevin Joseph
Tanguler Tolga
Garg Pushkal
Ausiello Dennis A
Sigal Charles Elliott
Bertozzi Carolyn R
Brandicourt Olivier
Hamburg Margaret A
Kellogg Peter N
Pyott David E I
Reitan Colleen F
Schulman Amy W
Hesslein Robert W.
Sharp Phillip A
Franchini Indrani Lall
Vaishnaw Akshay
Fanucci Marsha
Paul Steven M
Maraganore John
Keating Laurie
Greene Barry E
Schimmel Paul
Soni Manmeet Singh
Sanofi
Mason Michael
Clarke John K
Starr Kevin P
Gros David-Alexandre C
Regulus Therapeutics Inc.
Reid Laurence
Dzau Victor J
Novartis Pharma AG
Novartis AG
Form 13F Holdings
Firm Period DFND Voting Shares
Capital World Investors [2025-06-30] DFND 16,781,194 16,805,007
FMR LLC [2025-06-30] DFND 15,305,392 15,806,521
Vanguard Group Inc [2025-06-30] SOLE 0 12,947,241
BlackRock, Inc. [2025-06-30] SOLE 9,248,495 9,979,934
Capital Research Global Investors [2025-06-30] DFND 7,181,265 7,191,656
Regeneron Pharmaceuticals Inc [2025-06-30] SOLE 4,444,445 4,444,445
Dodge & Cox [2025-06-30] SOLE 3,002,221 3,197,096
State Street Corp [2025-06-30] DFND 2,560,247 3,173,105
Geode Capital Management LLC [2025-06-30] DFND 2,398,770 2,398,770
Baillie Gifford & Co [2025-06-30] DFND 2,132,268 2,267,557
Orbis Allan Gray Ltd [2025-06-30] DFND 2,121,412 2,121,412
Wellington Management Group LLP [2025-06-30] DFND 0 2,075,752
JPMorgan Chase & Co [2025-06-30] DFND 1,959,248 2,061,745
Norges Bank [2025-06-30] SOLE 2,032,680 2,032,680
American Century Companies Inc [2025-06-30] DFND 1,591,579 1,793,846
Invesco Ltd. [2025-06-30] DFND 0 1,341,694
Bank of America Corp /DE/ [2025-06-30] DFND 33,615 1,257,728
Legal & General Group Plc [2025-06-30] DFND 832,218 872,771
Northern Trust Corp [2025-06-30] DFND 823,961 830,241
Nuveen, LLC [2025-06-30] DFND 773,492 774,969
Morgan Stanley [2025-06-30] DFND 546,191 770,968
Baillie Gifford & Co [2025-06-30] SOLE 508,754 764,334
Winslow Capital Management LLC [2025-06-30] OTR 0 732,134
Citadel Advisors LLC [2025-06-30] DFND 700,799 700,799
Bellevue Group AG [2025-06-30] DFND 676,367 676,367
Woodline Partners LP [2025-06-30] SOLE 623,115 623,115
Franklin Resources Inc [2025-06-30] DFND 592,476 601,331
Macquarie Group Ltd [2025-06-30] SOLE 598,599 600,111
Holocene Advisors LP [2025-06-30] SOLE 596,816 596,816
Goldman Sachs Group Inc [2025-06-30] DFND 554,211 596,216
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com